Antimicrobial decapeptide KSL-W attenuates Candida albicans virulence by modulating its effects on Toll-like receptor, human β-defensin, and cytokine expression by engineered human oral mucosa. (Q51608171)
Jump to navigation
Jump to search
scientific article published on 2 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antimicrobial decapeptide KSL-W attenuates Candida albicans virulence by modulating its effects on Toll-like receptor, human β-defensin, and cytokine expression by engineered human oral mucosa. |
scientific article published on 2 February 2011 |
Statements
Antimicrobial decapeptide KSL-W attenuates Candida albicans virulence by modulating its effects on Toll-like receptor, human β-defensin, and cytokine expression by engineered human oral mucosa. (English)
1 reference
A Semlali
1 reference
K P Leung
1 reference
S Curt
1 reference
M Rouabhia
1 reference
2 February 2011
1 reference
32
1 reference
5
1 reference
859-867
1 reference